Castle Rock Wealth Management, LLC Medpace Holdings, Inc. Transaction History

Castle Rock Wealth Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$130.2 - $168.03 $179,806 - $232,049	-1,381 Closed	0 $0
Q1 2022 Apr 25, 2022	SELL	$138.87 - $214.31 $93,320 - $144,016	-672 Reduced 32.73%	1,381 $216,000
Q4 2021 Feb 02, 2022	SELL	$182.74 - $227.9 $73,278 - $91,387	-401 Reduced 16.34%	2,053 $338,000
Q3 2021 Nov 12, 2021	BUY	$170.18 - $198.21 $58,712 - $68,382	345 Added 16.36%	2,454 $551,000
Q2 2021 Aug 13, 2021	SELL	$158.62 - $194.3 $19,827 - $24,287	-125 Reduced 5.6%	2,109 $365,000
Q1 2021 Apr 27, 2021	BUY	$132.02 - $168.26 $17,426 - $22,210	132 Added 6.28%	2,234 $419,000
Q4 2020 Jan 29, 2021	BUY	$109.38 - $149.19 $229,916 - $313,597	2,102 New	2,102 $298,000
Q1 2020 May 18, 2020	SELL	$61.71 - $101.95 $144,463 - $238,664	-2,341 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$70.08 - $84.64 $164,057 - $198,142	2,341 New	2,341 $227,000
Q3 2019 Nov 13, 2019	SELL	$62.38 - $85.89 $238,728 - $328,701	-3,827 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$53.64 - $65.42 $205,280 - $250,362	3,827 New	3,827 $254,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Castle Rock Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Castle Rock Wealth Management, LLC with notifications on news.